{"SPADE_N_13781": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_N_13781", "Peptide Name": "FK-21 (LL-17-37, a pathogen-cleaved host peptide fragment, truncation, synthetic AMPs; fragment of LL-37, UCLL1)", "Source": "host-pathogen war, human cathelicidin analog, animal-derived, natural derivative", "Family": "Not found", "Gene": "Not found", "Sequence": "FKRIVQRIKDFLRNLVPRTES", "Sequence Length": 21, "UniProt Entry": "Ref", "Protein Existence": "Not found", "Biological Activity": ["Anti-Gram+", "Anti-Gram-"], "Target Organism": "Not found", "Hemolytic Activity": "Not found", "Cytotoxicity": "Not found", "Binding Target": "Not found", "Linear/Cyclic": "Not found", "N-terminal Modification": "Not found", "C-terminal Modification": "Not found", "Stereochemistry": "Not found", "Structure Description": "Not found", "Formula": "Not found", "Mass": 2616.07, "PI": 11.55, "Hydrophobicity": -0.59, "Half Life": "Not found", "Function": "Not found", "Literature": [{"Author": "Sieprawska-Lupa M, Mydel P, Krawczyk K, WÃ³jcik K, Puklo M, Lupa B, Suder P, Silberring J, Reed M, Pohl J, Shafer W, McAleese F, Foster T, Travis J, Potempa J.2004", "Reference": "Antimicrob Agents Chemother. 2004 Dec;48(12):4673-9. doi: 10.1128/AAC.48.12.4673-4679.2004.PubMed", "Title": "Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases"}], "Frequent Amino Acids": "RFI", "Absent Amino Acids": "ACGHMOUWY", "Basic Residues": 6, "Acidic Residues": 2, "Hydrophobic Residues": 9, "Polar Residues": 12, "Positive Residues": 6, "Negative Residues": 2, "Net Charge": 4, "Comments": "APD analysis reveals this sequence is most similar (96.67%) tohuman cathelicidin fragment KS-30GRAVY: -0.586; M. Wt: 2616.107; Mol formula: C118H200N36O30; Mol Ex Coeff: 0;pathogen cleavage: This peptide is a cleaved product of LL-37 by Staphylococcal aureus V8 protease at the Glu17-Phe17 bond. It cannot be further cleaved.Activity: It displayed actiity against S. aureus similar to LL-37. Active against E. coli (MBC 1.1 ug/ml), B. subtilis MBC 0.8 ug/ml), P. aeruginosa (MBC 1.6 ug/ml), and E. faecalis (MBC 4.5 ug/ml).", "Similar Sequences": [{"SPADE_ID": "SPADE_N_02277", "Similarity": 1.0, "Sequence": "GDFFRKSKEKIGKEFKRIVQRIKDFLRN"}, {"SPADE_ID": "SPADE_N_02334", "Similarity": 1.0, "Sequence": "LLGDFFRKAREKIGEEFKRIVQRIKDFLRNLVPRTES"}, {"SPADE_ID": "SPADE_N_03100", "Similarity": 1.0, "Sequence": "KSKEKIGKEFKRIVQRIKDFLRNLVPR"}]}}}